Diabetes drugmaker Novo Nordisk (NOVOb.CO) forecast a rise in underlying sales and profit for 2021 on Wednesday and said it expected more Americans to get access to its drugs under the new Biden ...
The CGM market presents significant opportunities driven by rising diabetes prevalence and technological advancements. Key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback